 multicent clinic trial epoetin beta anemia end-stag renal diseas patient anemia end-stag renal diseas week efficaci safeti long-term benefit epoetin beta administr total patient double-blind placebo-control portion multicent studi first week fixed-dos period patient u/kg epoetin beta placebo thrice second week dose-adjust period dose epoetin beta u/kg thrice patient placebo-control period open-label period patient activ drug dose epoetin beta first week patient studi phase studi beta consist sustain increas hemoglobin baselin g/dl hematocrit baselin need pack red blood cell transfus reticulocyt count respons beta level baselin remaind studi period baselin placebo group chang paramet double-blind period similar pattern respons origin placebo group crossov activ drug mean hemoglobin increas